Emergent BioSolutions | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
ALKERMES USD 1.48B 63.7M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amarin USD 573.06M 22.34M 2025-03
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Exact Sciences USD 1.37B 201.08M 2025-03
Exelixis USD 1.4B 71.08M 2025-04
Glaxosmithkline GBP 17B 301M 2024-12
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
Lonza CHF 5.44B 113M 2024-12
Merck USD 35.5B 3.28B 2025-03
Moderna USD 6.77B 1.33B 2025-03
Myriad Genetics USD 287.2M 10.8M 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Pacira USD 759.96M 14.83M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
PTC Therapeutics USD 2.32B 950.88M 2025-03
Sanofi 44.02B 1.43B 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
United Therapeutics USD 3.94B 65.9M 2025-03


Emergent BioSolutions Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.